Drug Type Small molecule drug |
Synonyms (+-)-Menthol, (1R,2S,5R)-Menthol, Folrex + [8] |
Target |
Action agonists |
Mechanism TRPA1 agonists(Transient receptor potential cation channel subfamily A member 1 agonists), TRPM8 agonists(Transient receptor potential cation channel subfamily M member 8 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC10H20O |
InChIKeyNOOLISFMXDJSKH-WYVCTLLJSA-N |
CAS Registry89-78-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis | - | - | - |
Sinusitis | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pharyngitis | Phase 3 | Russia | 22 Feb 2017 | |
Adenomatous Polyposis Coli | Phase 3 | Japan | 01 Sep 2011 | |
Castration-Resistant Prostatic Cancer | Phase 3 | Japan | 01 Sep 2011 | |
Early gastric cancer | Phase 3 | Japan | 01 Sep 2011 | |
Gastric adenoma | Phase 3 | Japan | 01 Sep 2011 | |
Dry Eye Syndromes | Phase 2 | Canada | - | 04 Aug 2025 |
Phase 3 | 229 | (Angal S (Arm A)) | pxwstavunt = vlxqczgaov sqbhttwfri (fcrqjfydjm, comvbrfqli - hrfkfkifpd) View more | - | 21 Mar 2019 | ||
ANTI-ANGIN® FORMULA, topical metered spray (ANTI-ANGIN® FORMULA (Arm B)) | pxwstavunt = zaxigncgmg sqbhttwfri (fcrqjfydjm, gkspkqanzj - nhmeoiupct) View more | ||||||
Not Applicable | 57 | npsttgowtd(xboalcvadg) = bpgjsjemip ihhagxowov (rswgdopcys, 0.3803) View more | - | 20 Feb 2019 | |||
npsttgowtd(xboalcvadg) = rwagrttglp ihhagxowov (rswgdopcys, 0.4292) View more | |||||||
Phase 2 | 32 | gncwslpwie(mxwcgtlsng) = fzuwhwgmgp zmqxitczbj (yxbtbgswnx, 2.7 - 32.4) | - | 20 May 2015 |